Cargando…

The Role of GLP-1 Signaling in Hypoglycemia due to Hyperinsulinism

Incretin hormones play an important role in the regulation of glucose homeostasis through their actions on the beta cells and other tissues. Glucagon-like peptide-1 (GLP-1) and glucose dependent insulinotropic polypeptide (GIP) are the two main incretins and are secreted by enteroendocrine L- and K-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danowitz, Melinda, De Leon, Diva D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987579/ https://www.ncbi.nlm.nih.gov/pubmed/35399928 http://dx.doi.org/10.3389/fendo.2022.863184

Ejemplares similares

Activation of Protein Kinase A (PKA) signaling mitigates congenital hyperinsulinism associated hypoglycemia in the Sur1(-/-) mouse model
por: Soundarapandian, Mangala M., et al.
Publicado: (2020)

MON-087 Natural History and Neurodevelopmental Outcomes in Perinatal Stress Induced Hyperinsulinism
por: Sigal, Winnie M, et al.
Publicado: (2020)

MON-110 Utilization of GluCEST, a Novel Neuroimaging Technique, to Characterize the Brain Phenotype in Hyperinsulinism/Hyperammonemia Syndrome
por: Rosenfeld, Elizabeth, et al.
Publicado: (2020)

Global Registries in Congenital Hyperinsulinism
por: Pasquini, Tai L. S., et al.
Publicado: (2022)

Syndromic forms of congenital hyperinsulinism
por: Zenker, Martin, et al.
Publicado: (2023)

Congenital Hyperinsulinism International: A Community Focused on Improving the Lives of People Living With Congenital Hyperinsulinism
por: Raskin, Julie, et al.
Publicado: (2022)

GLP-1 Receptor Antagonist Exendin-(9-39) Elevates Fasting Blood Glucose Levels in Congenital Hyperinsulinism Owing to Inactivating Mutations in the ATP-Sensitive K(+) Channel
por: Calabria, Andrew C., et al.
Publicado: (2012)

The Genetic and Molecular Mechanisms of Congenital Hyperinsulinism
por: Galcheva, Sonya, et al.
Publicado: (2019)

Somatostatin receptors in congenital hyperinsulinism: Biology to bedside
por: van Albada, Mirjam E., et al.
Publicado: (2022)

Possible New Strategies for the Treatment of Congenital Hyperinsulinism
por: Sikimic, Jelena, et al.
Publicado: (2020)

Extreme caution on the use of sirolimus for the congenital hyperinsulinism in infancy patient
por: Banerjee, Indraneel, et al.
Publicado: (2017)

Phenotypic Characterization of Congenital Hyperinsulinism Due to Novel Activating Glucokinase Mutations
por: Li, Changhong, et al.
Publicado: (2023)

Feeding Problems Are Persistent in Children with Severe Congenital Hyperinsulinism
por: Banerjee, Indraneel, et al.
Publicado: (2016)

Health-Related Quality of Life in Children With Congenital Hyperinsulinism
por: Männistö, Jonna M. E., et al.
Publicado: (2019)

Delayed Resolution of Feeding Problems in Patients With Congenital Hyperinsulinism
por: Worth, Chris, et al.
Publicado: (2020)

Emerging Role of Caveolin-1 in GLP-1 Action
por: Puddu, Alessandra, et al.
Publicado: (2021)

SAT-290 Expanded Phenotype Associated with RNF135 Intragenic Deletion in a Girl with Peripheral Precocious Puberty
por: Danowitz, Melinda, et al.
Publicado: (2019)

SAT-271 Higher C-Peptide Levels and Glucose Requirements May Identify Neonates with Transient Hyperinsulinism Hypoglycemia Who Will Benefit from Diazoxide Treatment
por: Schachter Davidov, Anita, et al.
Publicado: (2019)

Mosaic GLUD1 Mutations Associated with Hyperinsulinism Hyperammonemia Syndrome
por: Boodhansingh, Kara E., et al.
Publicado: (2022)

Case report: Two unexpected cases of DGUOK-related mitochondrial DNA depletion syndrome presenting with hyperinsulinemic hypoglycemia
por: Guzman, Herodes, et al.
Publicado: (2023)

Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital Hyperinsulinism
por: Avatapalle, Hima Bindu, et al.
Publicado: (2013)

Risk Factors for Adverse Neurodevelopment in Transient or Persistent Congenital Hyperinsulinism
por: Roeper, Marcia, et al.
Publicado: (2020)

Differential Morphological Diagnosis of Various Forms of Congenital Hyperinsulinism in Children
por: Mitrofanova, Lubov Borisovna, et al.
Publicado: (2021)

Congenital intrahepatic portocaval shunts and hypoglycemia due to secondary hyperinsulinism: a case report and review of the literature
por: Weigert, Alexander, et al.
Publicado: (2018)

Stem Cell Based Models in Congenital Hyperinsulinism – Perspective on Practicalities and Possibilities
por: Lithovius, Väinö, et al.
Publicado: (2022)

A Sensitive Plasma Insulin Immunoassay to Establish the Diagnosis of Congenital Hyperinsulinism
por: Siersbæk, Julie, et al.
Publicado: (2021)

Genotype-phenotype correlation in Taiwanese children with diazoxide-unresponsive congenital hyperinsulinism
por: Lee, Cheng-Ting, et al.
Publicado: (2023)

Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function
por: Rowlands, Jordan, et al.
Publicado: (2018)

Continuous Glucose Monitoring in the Management of Neonates With Persistent Hypoglycemia and Congenital Hyperinsulinism
por: Win, Myat, et al.
Publicado: (2021)

Insulin Immunoassay Interference Due to Human Antimouse Antibodies in a Patient With Ketotic Hypoglycemia
por: Craven, Meghan, et al.
Publicado: (2023)

PSUN339 Persistent Hypoglycemia and Hyperinsulinism in a Patient With Kabuki Syndrome Type 1.
por: Gomez, Patricia, et al.
Publicado: (2022)

Standardised practices in the networked management of congenital hyperinsulinism: a UK national collaborative consensus
por: Shaikh, M. Guftar, et al.
Publicado: (2023)

Characterizing the neurological phenotype of the hyperinsulinism hyperammonemia syndrome
por: Rosenfeld, Elizabeth, et al.
Publicado: (2022)

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD
por: Seghieri, Marta, et al.
Publicado: (2018)

Families’ Experiences of Continuous Glucose Monitoring in the Management of Congenital Hyperinsulinism: A Thematic Analysis
por: Auckburally, Sameera Hannah, et al.
Publicado: (2022)

Congenital Hyperinsulinism: Current Laboratory-Based Approaches to the Genetic Diagnosis of a Heterogeneous Disease
por: Hewat, Thomas I., et al.
Publicado: (2022)

The hypoglycaemia error grid: A UK-wide consensus on CGM accuracy assessment in hyperinsulinism
por: Worth, Chris, et al.
Publicado: (2022)

Efficacy of Dose-Titrated Glucagon Infusions in the Management of Congenital Hyperinsulinism: A Case Series
por: Salomon-Estebanez, Maria, et al.
Publicado: (2020)

Health-Related Quality of Life of Children and Adolescents With Congenital Hyperinsulinism – A Scoping Review
por: Kristensen, Kaja, et al.
Publicado: (2021)

GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach
por: Wang, Jing-Yue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8obkd3d824dc18kc7dqr28qgm3